The human neutrophil. Function and dysfunction

European Journal of Haematology

Volumn 41, Issue 5, 1988, Pages 401-413

  Borregaard, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

dysfunction; function; human neutrophil

Indexed keywords

ALKALINE PHOSPHATASE; MEMBRANE PROTEIN;

HUMAN; ISCHEMIC HEART DISEASE; MYELOPOIESIS; NEUTROPHIL; PHAGOCYTOSIS; REVIEW; STEM CELL;

BACTERIOLYSIS; CELL DIFFERENTIATION; HEMATOPOIESIS; HUMAN; INFLAMMATION; MEMBRANE PROTEINS; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NEUTROPHILS; OXYGEN; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0024240402     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1988.tb00219.x     Document Type: Review

References (129)

1. Elastases and emphysema. Current assessment of the protease‐antiprotease hypothesis
2. Granulocytes as active participants in acute myocardial ischemia and infarction
3. New mechanisms for glomerular injury. Myeloperxidase‐hydrogen peroxidehalide system
4. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance
5. Neutrophil dysfunction and recurrent infection
6. Disorders of phagocyte function
7. Polymorphonuclear leukocyte function
8. Disorders of polymorphonuclear function
9. Phagocyte defects
10. Neutrophils in human diseases
11. Disorders of phagocyte function
12. Hematopoietic growth factors
13. Why the kidney
14. Identification of lactoferrin as the granulocyte‐derived inhibitor of colony stimulating activity production
15. The biological significance of lactoferrin in haematology
16. A glycoprotein inhibitor of in vitro granulopoiesis, associated with AIDS
17. Recombinant human granulocyte‐macrophage colony‐stimulating factor stimulates in vitro mature neutrophil and eosinophil function, surface receptor expression and survival
18. Purification and functional evaluation of mature neutrophils from human bone marrow
19. Development of the phagocytic and cidal capacity during maturation of myeloid cells. Studies on cells from patients with chronic myelogenous leukaemia
20. Chemoattractant‐regulated mobilization of a novel intracellular compartment in human neutrophils
21. Release of gelatinase from a novel secretory compartment of human neutrophils
22. Ultrastructural localization of human neutrophil gelatinase
23. Abnormal stimulated adherence of neonatal granulocytes: Impaired induction of surface Mac‐1 by chemotactic factors and secretagogoues
24. Prenatal diagnosis of chronic granulomatous disease
25. Evidence that micro‐enciromental factors account for the age‐related decline in neutrophil function
26. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions
27. Human neutrophil heterogeneity exists, but is it meaningful
28. Identification and characterization of a unique subpopulation (Calla/CD 10‐negative) of human neutrophils manifesting a heightened chemotactic response to activated complement
29. A human leukocyte differentiation antigen family with distinct α‐sub‐units and common β‐subunits: The lymphocyte function associated antigen (LFA‐1), the C3bi complement receptor (OKM‐1/Mac‐1) and the p150,95 molecule
30. Leukocyte adhesion deficiency: An inherited defect in the Mac‐1. LFA‐1 and p 150,95 glycoproteins
31. Stimulated mobilization of monocyte Mac‐1 and p 150,95 adhesion proteins from an internal vesicular compartment to the cell surface
32. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils
33. Leukocyte adhesion receptors are stored in peroxidase negative granules of human neutrophils
34. Functional activity of enucleated human polymorphonuclear leukocytes
35. Expression of cell surface markers on the cell surface of neutrophil cytoplasts
36. Organelle‐depleted human neutrophil cytoplasts used to study fmet‐leu phe receptor modulation and cell function
37. Differentiation of cellular processes involved in the induction and maintenance of stimulated neutrophil adherence
38. 2+ dependent ATPase in human granulocytes
39. Purification and identification of formyl‐methionyl‐leucyl‐phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia Coli
40. Abnormal phagocyte chemotaxis: Pathophysiology, clinical manifestations, and management of patients
41. Neutrophil specific granule deficiency
42. Anomalous neutrophil granule distribution in a patient with lactoferrin deficiency: Pertinence to the respiratory burst
43. G proteins and dual control of adenylate cyclase
44. Ligand‐receptor dynamics and signal amplification in the neutrophil
45. A pertussis toxin‐sensitive GTP‐binding protein in the human neutrophil regulates multiple receptors, calcium mobilization, and lectin‐induced capping
46. Chemoattractant receptor induced hydrolysis of phosphatidylinositol 4,5‐bisphophate in human polymorphonuclear leukocyte membranes. Requirement for a guanine nucleotide regulatory protein
47. Pertussis‐toxin inhibits fmet‐leu‐phe but not phorbol ester stimulated changes in rabbit neutrophils: Role of G proteins in excitation response coupling
48. Inositol trisphosphate and diacylglycerol as second messengers
49. 2+ pumping sites in human neutrophils
50. The role of protein kinase C in cell surface signal transduction and tumour promotion
51. Phorbol myristate acetate receptors in human polymorphonuclear neutrophils
52. Protein kinase C and the activation of the human neutrophil NADPH‐oxidase
53. Mechanism of arachidonic acid release in human polymorphonuclear leukocytes
54. Leukotrienes; Mediators of immediate hypersensitivity reactions and inflammation
55. The biologically active leukotrienes: Biosynthesis, metabolism, receptors, functions and pharmacology
56. In vitro effect of hydrocortisone on the attachment and ingestion phases of immunoglobulin G‐ and complement 3b‐mediated phagocytosis by human neutrophils
57. Modes of action of aspirin‐like drugs
58. Modulation of gelsolin function by phosphatidylinositol 4,5‐bisphosphate
59. 2+
60. Secretory response of human neutrophils: Exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo
61. Membrane activity and topography of f‐met‐leu‐phe treated polymorphonuclear leukocytes. Acute and sustained responses to chemotactic peptide
62. Human neutrophil laminin receptors: Activation‐dependent receptor expression
63. Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis
64. Increased expression of complement decay‐accelerating factor during activation of human neutrophils
65. Secreted forms of human neutrophil collagenase
66. Degradation of heparan sulphate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils
67. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A 23187
68. Phagocytosis I, II, III
69. Endocytosis
70. 2+‐independent phagocytosis of human neutrophils
71. Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils
72. 2+ levels
73. Is a rise in intracellular concentration of free calcium necessary or sufficient for stimulated cytoskeletal associated actin
74. 2+‐dependent binding of proteins associated with chromaffin granules
75. Human polymorphonuclear leukocytes contain synexin, a calcium‐binding protein that mediates membrane infusion
76. Alkalinizing the intragranular pH inhibits degranulation of human neutrophils
77. Acid‐vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum
78. Characterization of the chemotactic defect in polymorphonuclear leukocytes exposed to influenza virus in vitro
79. Two genetic disorders that affect human neutrophils are associated with deficiencies of microbicidal and cytotoxic proteins
80. Neutrophil actin dysfunction and abnormal neutrophil behavior
81. Neutrophil actin dysfunction is associated with a deficiency of Mol
82. 2‐independent microbicidal systems of phagocytes
83. Nonoxidative antimicrobial reactions of leukocytes
84. Cellular and subscellular localization of the bacteridcidal/permeability increasing proteins of neutrophils
85. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils
86. Defensins. Natural peptide antibiotics of human neutrophils
87. Preliminary structures of three human neutrophil defensins
88. Defensin‐rich dense granules of human neutrophils
89. The extra respiration of phagocytosis
90. The respiratory burst. An overview
91. Subcellular localization of the superoxide‐forming enzyme in human neutrophils
92. Subcellular localization of the human neutrophil NADPH oxidase: b‐cytochrome and associated flavoprotein
93. 2 pool generated by human neutrophils
94. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation
95. The respiratory burst of phagocytosis is associated with a rise in vacuolar pH
96. Biosynthesis and processing of myeloperoxidase — a marker for myeloid cell differentiation
97. Hydroxyl radical generation by polymorphonuclear leukocytes measured by electron spin resonance spectroscopy
98. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies
99. The respiratory burst of human neutrophils. Further studies of the purified enzyme
100. Activation of NADPH‐dependent superoxide production in a cell free system by sodium dodecyl sulfate
101. Activation of neutrophil NADPH oxidase in a cell free system. Partial purification of components and characterization of the activation process
102. ‐245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance
103. The glycoprotein encoded by the X‐linked chronic granulomatous disease is a component of the neutrophil cytochrome b complex
104. ‐245
105. 558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their mothers
106. ‐245 by NADPH
107. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000
108. 245 subunits from neutrophils in X‐linked chronic granulomatous disease
109. ‐245 of neutrophils is also present in human monocytes, macrophages and eosinophils
110. Cloning the gene for an inherited human disorder — chronic granulomatous disease — on the basis of its chromosomal location
111. Superoxide‐forming enzyme from human neutrophils: Evidence for a flavin requirement
112. Reevaluation of cytochrome b and flavin adenine nucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with possible autosomal recessive inheritance of cytochrome b deficiency
113. A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b and flavoprotein
114. Subcellular localization of the b‐cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation
115. NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate‐activatable superoxide generating system
116. Difference in extracellular radical release after chemotactic factor and calcium ionophore activation of the oxygen radical‐generating system in human neutrophils
117. 3
118. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr‐44,0000 protein
119. A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils. Evidence from studies with cells from patients with chronic granulomatous disease
120. Diacylglycerol accumulation and superoxide anion production in stimulated human neutrophils
121. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization
122. Reduction of experimental canine myocardial ischemia and reperfusion by a monoclonal antibody (anti ‐Mol) that inhibits leukocyte adhesion